When will Dextrose Monohydrate 50% Injection be back in stock?

The FDA lists an estimated recovery date per manufacturer where known; check the FDA note column below. National FDA records do not reflect your local pharmacy's shelf.

How do I get an alert when Dextrose Monohydrate 50% Injection changes?

Sign up for a change-only email alert on this page, or subscribe to the RSS or JSON feed. You are notified only when the FDA record changes.

← all medications

Dextrose Monohydrate 50% Injection

Brand names: Dextrose, Dextrose Monohydrate

Category: Endocrinology/Metabolism, Gastroenterology, Pediatric

Limited 1Available 2Not specified 1

FDA status: Current, To Be Discontinued · Last FDA update: Nov 7, 2025 · First posted: Jan 13, 2022 (in shortage 4 years 8 months) · 2 manufacturers, 4 listed presentations

As of Nov 7, 2025, the FDA lists Dextrose Monohydrate 50% Injection as being discontinued. Of 4 manufacturer presentations, 1 Limited, 2 Available, 1 Not specified.

Ask your pharmacist: which of the 2 manufacturers below can they order right now, and whether a different strength or form of Dextrose Monohydrate 50% Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.

Presentation & package NDC	Manufacturer	Availability	FDA note
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02) NDC 0409-6648-02	Hospira, Inc., a Pfizer Company	Limited	Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1) NDC 76329-3302-1	Amphastar Pharmaceuticals, Inc.	Available	-
Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16) NDC 0409-7517-16	Hospira, Inc., a Pfizer Company	Available	-
Dextrose Monohydrate 50%, Injection, 50% Dextrose Injection 0.5 g/mL; ABBOJECT® Glass Syringe (NDC 0409-4902-34) NDC 0409-4902-34	Hospira, Inc., a Pfizer Company	Not specified	Discontinuation of the manufacture of the drug

Related medications in shortage

Other Endocrinology/Metabolism, Gastroenterology, Pediatric medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Dextrose Monohydrate 50% Injection (FDA data as of Nov 7, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Dextrose Monohydrate 50% Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Dextrose Monohydrate 50% Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/dextrose-monohydrate-50-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).